Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 291

1.

Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma.

Kim WY, Kim HY, Son GS, Bae JW, Lee JB.

J Cancer Res Ther. 2014 Jan-Mar;10(1):50-5. doi: 10.4103/0973-1482.131366.

2.

Minimal extrathyroidal extension in patients with papillary thyroid microcarcinoma: is it a real prognostic factor?

Moon HJ, Kim EK, Chung WY, Yoon JH, Kwak JY.

Ann Surg Oncol. 2011 Jul;18(7):1916-23. doi: 10.1245/s10434-011-1556-z. Epub 2011 Jan 26.

PMID:
21267788
3.

Clinical impact of microscopic extrathyroidal extension in patients with papillary thyroid microcarcinoma treated with hemithyroidectomy.

Ahn D, Sohn JH, Jeon JH, Jeong JY.

J Endocrinol Invest. 2014 Feb;37(2):167-73. doi: 10.1007/s40618-013-0025-x. Epub 2014 Jan 9.

PMID:
24497215
4.

[Invasiveness of papillary thyroid microcarcinoma with BRAF mutation].

Yang X, Liang ZY, Meng C, Liang J, Yu Z, Lin YS.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013 Aug;35(4):398-403. doi: 10.3881/j.issn.1000-503X.2013.04.008. Chinese.

5.

Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.

Karatzas T, Vasileiadis I, Kapetanakis S, Karakostas E, Chrousos G, Kouraklis G.

Am J Surg. 2013 Oct;206(4):586-93. doi: 10.1016/j.amjsurg.2013.02.008. Epub 2013 Jun 19.

PMID:
23790258
6.
7.

Factors predictive of papillary thyroid micro-carcinoma with bilateral involvement and central lymph node metastasis: a retrospective study.

Zhou YL, Gao EL, Zhang W, Yang H, Guo GL, Zhang XH, Wang OC.

World J Surg Oncol. 2012 May 19;10:67. doi: 10.1186/1477-7819-10-67.

8.

Prognostic significance of tumor multifocality in papillary thyroid carcinoma and its relationship with primary tumor size: a retrospective study of 2,309 consecutive patients.

Kim KJ, Kim SM, Lee YS, Chung WY, Chang HS, Park CS.

Ann Surg Oncol. 2015 Jan;22(1):125-31. doi: 10.1245/s10434-014-3899-8. Epub 2014 Aug 5.

PMID:
25092159
9.

A retrospective analysis of prognostic factors predictive of lymph-node metastasis and recurrence in thyroid papillary microcarcinoma.

Usluogullari CA, Onal ED, Ozdemir E, Ucler R, Kiyak G, Ersoy PE, Yalcin S, G├╝ler G, Ersoy R, Cakir B.

Minerva Endocrinol. 2015 Mar;40(1):15-22. Epub 2014 Apr 3.

PMID:
24699706
10.

Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients.

Vasileiadis I, Karatzas T, Vasileiadis D, Kapetanakis S, Charitoudis G, Karakostas E, Kouraklis G.

Head Neck. 2014 Apr;36(4):564-70. doi: 10.1002/hed.23333. Epub 2013 Jun 18.

PMID:
23780707
11.

Central lymph node metastasis is an important prognostic factor in patients with papillary thyroid microcarcinoma.

Lee J, Song Y, Soh EY.

J Korean Med Sci. 2014 Jan;29(1):48-52. doi: 10.3346/jkms.2014.29.1.48. Epub 2013 Dec 26.

12.

[Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].

Shi CL, Guo Y, Lyu YC, Nanding ZABYS, Gao WC, Shi TF, Qin HD, Liu SY.

Zhonghua Zhong Liu Za Zhi. 2017 May 23;39(5):361-366. doi: 10.3760/cma.j.issn.0253-3766.2017.05.008. Chinese.

PMID:
28535653
13.

Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma.

Kim HJ, Kim NK, Choi JH, Kim SW, Jin SM, Suh S, Bae JC, Min YK, Chung JH, Kim SW.

Clin Endocrinol (Oxf). 2013 Apr;78(4):614-20. doi: 10.1111/cen.12034.

PMID:
22957654
14.

Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two?

Arora N, Turbendian HK, Kato MA, Moo TA, Zarnegar R, Fahey TJ 3rd.

Thyroid. 2009 May;19(5):473-7. doi: 10.1089/thy.2008.0185.

PMID:
19348582
15.

Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.

Shi C, Guo Y, Lv Y, Nanding A, Shi T, Qin H, He J.

PLoS One. 2016 Dec 9;11(12):e0167414. doi: 10.1371/journal.pone.0167414. eCollection 2016.

16.

Clinicopathological Significance of Minimal Extrathyroid Extension in Solitary Papillary Thyroid Carcinomas.

Woo CG, Sung CO, Choi YM, Kim WG, Kim TY, Shong YK, Kim WB, Hong SJ, Song DE.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S728-33. doi: 10.1245/s10434-015-4659-0. Epub 2015 Jun 16.

17.

Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients.

Zhang L, Wei WJ, Ji QH, Zhu YX, Wang ZY, Wang Y, Huang CP, Shen Q, Li DS, Wu Y.

J Clin Endocrinol Metab. 2012 Apr;97(4):1250-7. doi: 10.1210/jc.2011-1546. Epub 2012 Feb 8.

PMID:
22319042
18.

Prognostic parameters for recurrence of papillary thyroid microcarcinoma.

Kim TY, Hong SJ, Kim JM, Kim WG, Gong G, Ryu JS, Kim WB, Yun SC, Shong YK.

BMC Cancer. 2008 Oct 14;8:296. doi: 10.1186/1471-2407-8-296.

19.

Implication of minimal extrathyroidal extension as a prognostic factor in papillary thyroid carcinoma.

Shin JH, Ha TK, Park HK, Ahn MS, Kim KH, Bae KB, Kim TH, Choi CS, Kim TK, Bae SK, Kim SH.

Int J Surg. 2013;11(9):944-7. doi: 10.1016/j.ijsu.2013.06.015. Epub 2013 Jun 29.

20.

Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area.

Lombardi CP, Bellantone R, De Crea C, Paladino NC, Fadda G, Salvatori M, Raffaelli M.

World J Surg. 2010 Jun;34(6):1214-21. doi: 10.1007/s00268-009-0375-x.

PMID:
20052467

Supplemental Content

Support Center